VP16-213 (etoposide). A critical review of its activity.
D004341:Drug Evaluation; D005047:Etoposide / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D011034:Podophyllotoxin / Q000031:analogs & derivatives*; D012107:Research Design
D005047:Etoposide; D011034:Podophyllotoxin